Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 24;15:289–297. doi: 10.2147/BTT.S323358

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Kurdi et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The recurrence interval among glioblastoma patients, with WT1 overexpression and different IDH1 status, who received different treatment modalities.

Notes: (A) The association between chemotherapies and IDH1 mutation (blue curve: IDH1 mutant with TMZ; red curve: IDH1 mutant with only TMZ and other chemotherapies). (B) The association between chemotherapies and wildtype IDH1 (blue curve: IDH1 wildtype with TMZ and other chemotherapies; red curve: IDH1 wildtype with only TMZ).